市場調査レポート

商品コード

1403384

医療用ハイパースペクトルイメージングの世界市場予測（～2030年）：製品、技術、用途、エンドユーザー、地域別の分析

Medical Hyperspectral Imaging Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography

出版日: 2024年01月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の医療用ハイパースペクトルイメージングの市場規模は、2023年に18億米ドルを占め、予測期間中のCAGRは15.1％で成長し、2030年には49億米ドルに達する見込みです。

ハイパースペクトルイメージング（HSI）は、医療で使用される新しく開発されたイメージング手法で、特に画像誘導手術や病気の特定に有用です。2つの空間次元と1つのスペクトル次元を持つハイパーキューブデータセットは、HSIによって取得されます。空間的に分解されたスペクトルイメージングを通して、HSIは組織の生理学、形状、組成に関する診断情報を提供します。

国際がん研究機関（IARC）によると、2020年には190万人以上の大腸がん患者が新たに報告され、93万人が死亡しました。この統計は、2040年までに年間ベースでそれぞれ63％（320万人）、73％（160万人）増加すると予測されています。

がん有病率の上昇

医療用ハイパースペクトルイメージングの主な用途の1つは固形腫瘍の検出です。がん診断の非侵襲性、組織生検の省略、リアルタイムの造影剤を必要としない診断シグネチャの提供は、ハイパースペクトルイメージングに関連する主な利点の一部です。さらに、ハイパースペクトルイメージング市場は、がん罹患率の上昇により拍車がかかった医療用ハイパースペクトルイメージングに対する需要の高まりの結果として成長しています。

医療用ハイパースペクトルイメージングシステムの過剰コスト

ハイパースペクトル画像システムのコストには、ハイパースペクトルカメラ、光源、ソフトウェア、反射率パネル、顕微鏡、追加アクセサリの価格が含まれています。しかし、ハイパースペクトルカメラと顕微鏡にかかる費用は、決められた予算内で治療を提供する医療システムの能力を圧迫します。例えば、ハイパースペクトルカメラは中国のOptoskyが製造しており、その価格は45,000米ドルから48,800米ドルです。この方式は米国では50,000米ドルから始まることが多いです。

医療への応用を探る研究の高まり

ハイパースペクトルシステムはまだ医療への応用が模索されている段階であるため、病気の診断のために多くの研究が行われています。2023年1月のNCBI調査報告書によると、ハイパースペクトル画像は糖尿病性足潰瘍の治癒速度を予測するのに利用できるとのことです。この研究結果によると、ハイパースペクトル画像は、通常の臨床診療に容易に取り入れることができる安価な検査であり、糖尿病性足潰瘍の治癒能力に関する重要な洞察を提供する可能性があります。

大規模データ保存

データが複雑であるため、大容量の記憶領域が必要となり、市場拡大が制限され、企業にとっては安価ではありません。例えば、2022年4月のHindawiの論文によると、機械学習や深層学習と組み合わせたハイパースペクトル画像システムにとって、バルクデータストレージは高い空間複雑性を引き起こします。しかし、テストと学習が必要なHSIの生データが大量にあるため、時間がかかります。このため、予測期間を通じて市場の成長は制限されます。

COVID-19の影響：

2019年12月の発生以来、世界213カ国以上に拡大したため、世界保健機関は2020年3月に公衆衛生上の緊急事態を宣言しました。COVID-19パンデミックは、米国、中国、日本、インド、ドイツなどの主要国で長引くロックダウンをもたらし、重要製品に該当しない製造施設の停止につながりました。このため、世界中の産業施設の大半が閉鎖か生産停止に追い込まれました。

予測期間中、カメラ部門が最大となる見込み

イメージング機器は治療法や診断精度の向上に不可欠であるため、カメラ部門が最大のシェアを占めています。ハイパースペクトルカメラが記録できる波長範囲が広いため、生体組織を非常に詳細に分析し、障害の検出を改善することが可能です。さらに、ハイパースペクトルイメージングのリアルタイム組織識別、病気検出、手術ガイダンスなどの用途への利用が拡大していることも需要増に寄与しています。これらのカメラは、医療専門家に組織組成に関する独自の洞察を提供することで、早期発見や治療計画に役立っています。

予測期間中、眼科分野のCAGRが最も高くなる見込み

眼科診断を一変させる医療用ハイパースペクトルイメージングには特別な力があるため、眼科分野は利益を上げて成長すると予測されています。眼科における医療用ハイパースペクトルイメージングは、網膜組織に対する包括的な洞察を提供し、加齢黄斑変性や糖尿病性網膜症などの様々な眼疾患の正確な診断を可能にします。さらに、眼組織からスペクトル情報を抽出するこの技術は、異常の早期診断に役立ち、カスタマイズされた治療に有用な情報を提供します。

最もシェアの高い地域：

医療の進歩と技術利用の拡大により、アジア太平洋地域が最大のシェアを占めています。この地域の人口増加と医療インフラへの投資増加により、最新の医療イメージング技術の需要が高まっています。ハイパースペクトルイメージングが病気の診断や外科手術の正確性を向上させるために広範なスペクトル情報を提供する能力は、この地域の最先端医療技術への注目の高まりと一致しています。さらに、がんや心血管障害のような慢性疾患の蔓延が最先端の診断ツールに対する需要を高めており、ハイパースペクトル画像は画期的な治療法として提供されています。

CAGRが最も高い地域：

アジア太平洋地域は、中国、インド、日本のような医療インフラと研究能力を支援する政府の取り組みにより、有利な成長を維持すると予想されます。同地域では、強固な研究コミュニティや学術機関と業界関係者との協力関係により、技術革新が継続的に推進されています。さらに、眼科、皮膚科、腫瘍科など幅広い医療用途におけるハイパースペクトルイメージングの利点について、医療専門家の間で専門知識が高まっていることも、広く受け入れられる原動力となっています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

Applied Spectral Imaging Inc
Bayspec Inc
Cubert GmbH
HyVista Corporation Pty Ltd
Inno-Spec GmbH
ITRES Research Limited
Norsk Elektro Optikk AS
Photonics Science Co
Resonon, Inc
Si-Ware Systems
Specim Spectral Imaging Ltd.
Surface Optics Corporation
Tetracam Inc

図表

List of Tables

Table 1 Global Medical Hyperspectral Imaging Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Medical Hyperspectral Imaging Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Medical Hyperspectral Imaging Market Outlook, By Accessories (2021-2030) ($MN)
Table 4 Global Medical Hyperspectral Imaging Market Outlook, By Cameras (2021-2030) ($MN)
Table 5 Global Medical Hyperspectral Imaging Market Outlook, By Portable Devices (2021-2030) ($MN)
Table 6 Global Medical Hyperspectral Imaging Market Outlook, By Endoscopic Hyperspectral Imaging Devices (2021-2030) ($MN)
Table 7 Global Medical Hyperspectral Imaging Market Outlook, By Integrated Systems (2021-2030) ($MN)
Table 8 Global Medical Hyperspectral Imaging Market Outlook, By Other Products (2021-2030) ($MN)
Table 9 Global Medical Hyperspectral Imaging Market Outlook, By Technology (2021-2030) ($MN)
Table 10 Global Medical Hyperspectral Imaging Market Outlook, By Whiskbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 11 Global Medical Hyperspectral Imaging Market Outlook, By Snapshot Hyperspectral Imaging (2021-2030) ($MN)
Table 12 Global Medical Hyperspectral Imaging Market Outlook, By Pushbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 13 Global Medical Hyperspectral Imaging Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 14 Global Medical Hyperspectral Imaging Market Outlook, By Application (2021-2030) ($MN)
Table 15 Global Medical Hyperspectral Imaging Market Outlook, By Dermatology (2021-2030) ($MN)
Table 16 Global Medical Hyperspectral Imaging Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 17 Global Medical Hyperspectral Imaging Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 18 Global Medical Hyperspectral Imaging Market Outlook, By Surgical Imaging (2021-2030) ($MN)
Table 19 Global Medical Hyperspectral Imaging Market Outlook, By Other Applications (2021-2030) ($MN)
Table 20 Global Medical Hyperspectral Imaging Market Outlook, By End User (2021-2030) ($MN)
Table 21 Global Medical Hyperspectral Imaging Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 22 Global Medical Hyperspectral Imaging Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
Table 23 Global Medical Hyperspectral Imaging Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 24 Global Medical Hyperspectral Imaging Market Outlook, By Other End Users (2021-2030) ($MN)
Table 25 North America Medical Hyperspectral Imaging Market Outlook, By Country (2021-2030) ($MN)
Table 26 North America Medical Hyperspectral Imaging Market Outlook, By Product (2021-2030) ($MN)
Table 27 North America Medical Hyperspectral Imaging Market Outlook, By Accessories (2021-2030) ($MN)
Table 28 North America Medical Hyperspectral Imaging Market Outlook, By Cameras (2021-2030) ($MN)
Table 29 North America Medical Hyperspectral Imaging Market Outlook, By Portable Devices (2021-2030) ($MN)
Table 30 North America Medical Hyperspectral Imaging Market Outlook, By Endoscopic Hyperspectral Imaging Devices (2021-2030) ($MN)
Table 31 North America Medical Hyperspectral Imaging Market Outlook, By Integrated Systems (2021-2030) ($MN)
Table 32 North America Medical Hyperspectral Imaging Market Outlook, By Other Products (2021-2030) ($MN)
Table 33 North America Medical Hyperspectral Imaging Market Outlook, By Technology (2021-2030) ($MN)
Table 34 North America Medical Hyperspectral Imaging Market Outlook, By Whiskbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 35 North America Medical Hyperspectral Imaging Market Outlook, By Snapshot Hyperspectral Imaging (2021-2030) ($MN)
Table 36 North America Medical Hyperspectral Imaging Market Outlook, By Pushbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 37 North America Medical Hyperspectral Imaging Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 38 North America Medical Hyperspectral Imaging Market Outlook, By Application (2021-2030) ($MN)
Table 39 North America Medical Hyperspectral Imaging Market Outlook, By Dermatology (2021-2030) ($MN)
Table 40 North America Medical Hyperspectral Imaging Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 41 North America Medical Hyperspectral Imaging Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 42 North America Medical Hyperspectral Imaging Market Outlook, By Surgical Imaging (2021-2030) ($MN)
Table 43 North America Medical Hyperspectral Imaging Market Outlook, By Other Applications (2021-2030) ($MN)
Table 44 North America Medical Hyperspectral Imaging Market Outlook, By End User (2021-2030) ($MN)
Table 45 North America Medical Hyperspectral Imaging Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 46 North America Medical Hyperspectral Imaging Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
Table 47 North America Medical Hyperspectral Imaging Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 48 North America Medical Hyperspectral Imaging Market Outlook, By Other End Users (2021-2030) ($MN)
Table 49 Europe Medical Hyperspectral Imaging Market Outlook, By Country (2021-2030) ($MN)
Table 50 Europe Medical Hyperspectral Imaging Market Outlook, By Product (2021-2030) ($MN)
Table 51 Europe Medical Hyperspectral Imaging Market Outlook, By Accessories (2021-2030) ($MN)
Table 52 Europe Medical Hyperspectral Imaging Market Outlook, By Cameras (2021-2030) ($MN)
Table 53 Europe Medical Hyperspectral Imaging Market Outlook, By Portable Devices (2021-2030) ($MN)
Table 54 Europe Medical Hyperspectral Imaging Market Outlook, By Endoscopic Hyperspectral Imaging Devices (2021-2030) ($MN)
Table 55 Europe Medical Hyperspectral Imaging Market Outlook, By Integrated Systems (2021-2030) ($MN)
Table 56 Europe Medical Hyperspectral Imaging Market Outlook, By Other Products (2021-2030) ($MN)
Table 57 Europe Medical Hyperspectral Imaging Market Outlook, By Technology (2021-2030) ($MN)
Table 58 Europe Medical Hyperspectral Imaging Market Outlook, By Whiskbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 59 Europe Medical Hyperspectral Imaging Market Outlook, By Snapshot Hyperspectral Imaging (2021-2030) ($MN)
Table 60 Europe Medical Hyperspectral Imaging Market Outlook, By Pushbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 61 Europe Medical Hyperspectral Imaging Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 62 Europe Medical Hyperspectral Imaging Market Outlook, By Application (2021-2030) ($MN)
Table 63 Europe Medical Hyperspectral Imaging Market Outlook, By Dermatology (2021-2030) ($MN)
Table 64 Europe Medical Hyperspectral Imaging Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 65 Europe Medical Hyperspectral Imaging Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 66 Europe Medical Hyperspectral Imaging Market Outlook, By Surgical Imaging (2021-2030) ($MN)
Table 67 Europe Medical Hyperspectral Imaging Market Outlook, By Other Applications (2021-2030) ($MN)
Table 68 Europe Medical Hyperspectral Imaging Market Outlook, By End User (2021-2030) ($MN)
Table 69 Europe Medical Hyperspectral Imaging Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 70 Europe Medical Hyperspectral Imaging Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
Table 71 Europe Medical Hyperspectral Imaging Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 72 Europe Medical Hyperspectral Imaging Market Outlook, By Other End Users (2021-2030) ($MN)
Table 73 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Country (2021-2030) ($MN)
Table 74 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Product (2021-2030) ($MN)
Table 75 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Accessories (2021-2030) ($MN)
Table 76 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Cameras (2021-2030) ($MN)
Table 77 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Portable Devices (2021-2030) ($MN)
Table 78 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Endoscopic Hyperspectral Imaging Devices (2021-2030) ($MN)
Table 79 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Integrated Systems (2021-2030) ($MN)
Table 80 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Other Products (2021-2030) ($MN)
Table 81 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Technology (2021-2030) ($MN)
Table 82 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Whiskbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 83 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Snapshot Hyperspectral Imaging (2021-2030) ($MN)
Table 84 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Pushbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 85 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 86 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Application (2021-2030) ($MN)
Table 87 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Dermatology (2021-2030) ($MN)
Table 88 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 89 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 90 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Surgical Imaging (2021-2030) ($MN)
Table 91 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Other Applications (2021-2030) ($MN)
Table 92 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By End User (2021-2030) ($MN)
Table 93 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 94 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
Table 95 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 96 Asia Pacific Medical Hyperspectral Imaging Market Outlook, By Other End Users (2021-2030) ($MN)
Table 97 South America Medical Hyperspectral Imaging Market Outlook, By Country (2021-2030) ($MN)
Table 98 South America Medical Hyperspectral Imaging Market Outlook, By Product (2021-2030) ($MN)
Table 99 South America Medical Hyperspectral Imaging Market Outlook, By Accessories (2021-2030) ($MN)
Table 100 South America Medical Hyperspectral Imaging Market Outlook, By Cameras (2021-2030) ($MN)
Table 101 South America Medical Hyperspectral Imaging Market Outlook, By Portable Devices (2021-2030) ($MN)
Table 102 South America Medical Hyperspectral Imaging Market Outlook, By Endoscopic Hyperspectral Imaging Devices (2021-2030) ($MN)
Table 103 South America Medical Hyperspectral Imaging Market Outlook, By Integrated Systems (2021-2030) ($MN)
Table 104 South America Medical Hyperspectral Imaging Market Outlook, By Other Products (2021-2030) ($MN)
Table 105 South America Medical Hyperspectral Imaging Market Outlook, By Technology (2021-2030) ($MN)
Table 106 South America Medical Hyperspectral Imaging Market Outlook, By Whiskbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 107 South America Medical Hyperspectral Imaging Market Outlook, By Snapshot Hyperspectral Imaging (2021-2030) ($MN)
Table 108 South America Medical Hyperspectral Imaging Market Outlook, By Pushbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 109 South America Medical Hyperspectral Imaging Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 110 South America Medical Hyperspectral Imaging Market Outlook, By Application (2021-2030) ($MN)
Table 111 South America Medical Hyperspectral Imaging Market Outlook, By Dermatology (2021-2030) ($MN)
Table 112 South America Medical Hyperspectral Imaging Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 113 South America Medical Hyperspectral Imaging Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 114 South America Medical Hyperspectral Imaging Market Outlook, By Surgical Imaging (2021-2030) ($MN)
Table 115 South America Medical Hyperspectral Imaging Market Outlook, By Other Applications (2021-2030) ($MN)
Table 116 South America Medical Hyperspectral Imaging Market Outlook, By End User (2021-2030) ($MN)
Table 117 South America Medical Hyperspectral Imaging Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 118 South America Medical Hyperspectral Imaging Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
Table 119 South America Medical Hyperspectral Imaging Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 120 South America Medical Hyperspectral Imaging Market Outlook, By Other End Users (2021-2030) ($MN)
Table 121 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Country (2021-2030) ($MN)
Table 122 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Product (2021-2030) ($MN)
Table 123 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Accessories (2021-2030) ($MN)
Table 124 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Cameras (2021-2030) ($MN)
Table 125 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Portable Devices (2021-2030) ($MN)
Table 126 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Endoscopic Hyperspectral Imaging Devices (2021-2030) ($MN)
Table 127 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Integrated Systems (2021-2030) ($MN)
Table 128 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Other Products (2021-2030) ($MN)
Table 129 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Technology (2021-2030) ($MN)
Table 130 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Whiskbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 131 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Snapshot Hyperspectral Imaging (2021-2030) ($MN)
Table 132 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Pushbroom Hyperspectral Imaging (2021-2030) ($MN)
Table 133 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 134 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Application (2021-2030) ($MN)
Table 135 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Dermatology (2021-2030) ($MN)
Table 136 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 137 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 138 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Surgical Imaging (2021-2030) ($MN)
Table 139 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Other Applications (2021-2030) ($MN)
Table 140 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By End User (2021-2030) ($MN)
Table 141 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 142 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
Table 143 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 144 Middle East & Africa Medical Hyperspectral Imaging Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24609

According to Stratistics MRC, the Global Medical Hyperspectral Imaging Market is accounted for $1.8 billion in 2023 and is expected to reach $4.9 billion by 2030 growing at a CAGR of 15.1% during the forecast period. Hyperspectral imaging (HSI), a newly developed imaging method used in medicine, is especially useful for image-guided surgery and the identification of illnesses. The hypercube dataset, which has two spatial dimensions and one spectral dimension, is acquired through HSI. Through spatially resolved spectrum imaging, HSI provides diagnostic information on tissue physiology, shape, and composition.

According to the International Agency for Research on Cancer (IARC), in 2020, more than 1.9 million new cases of colorectal were reported leading to 930,000 deaths. The mentioned statistics are predicted to increase by 63% (3.2 million new cases) and 73% (1.6 million), respectively, by 2040 on an annual basis.

Market Dynamics:

Driver:

Rising prevalence of cancer

One of the main uses of medical hyperspectral imaging is solid tumor detection. The non-invasive nature of cancer diagnosis, the omission of tissue biopsies, and the provision of diagnostic signatures without the requirement for a real-time contrast agent are some of the primary benefits linked to hyperspectral imaging. Furthermore, the market is growing as a result of the rising demand for medical hyperspectral imaging spurred on by the rising incidence of cancer.

Restraint:

Excessive cost of hyperspectral medical imaging systems

The price of the hyperspectral camera, light sources, software, reflectance panel, microscope, and additional accessories have been included in the cost of a hyperspectral imaging system. However, the expense of hyperspectral cameras and microscopes strains the healthcare system's ability to provide treatment within the allotted budget. For instance, hyperspectral cameras are produced by the Chinese business Optosky, and they cost between $45,000 and $48,800. This method frequently begins at USD 50,000 and rises upwards in the US.

Opportunity:

Rising research to explore medical applications

As hyperspectral systems are still in their exploratory stages of usage in medicine, many studies are being conducted to diagnose diseases. A January 2023 NCBI research report states that hyperspectral imaging can be used to forecast the rate at which diabetic foot ulcers will heal. According to the study's results, hyperspectral imaging is an inexpensive test that can be readily included in regular clinical practice and may offer significant insights into DFU's capacity to heal.

Threat:

Large-scale data storage

Due to the complexity of data, large storage areas are required, which limits market expansion and is not inexpensive for businesses. For instance, bulk data storage causes high space complexity for hyperspectral imaging systems combined with machine and deep learning, according to a Hindawi paper from April 2022. However, it takes a long time because of the massive amount of raw HSI data that needs to be tested and trained. This restricts market growth throughout the projection period.

COVID-19 Impact:

The World Health Organization declared the disease a public health emergency in March 2020 after it spread to over 213 nations worldwide since the outbreak in December 2019. The COVID-19 pandemic resulted in a protracted lockdown in major nations such as the United States, China, Japan, India, and Germany, which led to the suspension of manufacturing facilities that do not correspond to critical products. It caused the majority of industrial facilities worldwide to either close or halt their production.

The cameras segment is expected to be the largest during the forecast period

Because imaging instruments are essential for improving therapeutic treatments and diagnostic accuracy, the cameras portion held the largest share. The wide range of wavelengths that hyperspectral cameras can record enables it feasible to analyze biological tissues in enormous detail and improve the detection of disorders. Additionally, the growing use of hyperspectral imaging for applications like real-time tissue distinction, illness detection, and surgical guidance is contributing to the demand increase. These cameras help with early detection and treatment planning by providing healthcare professionals with unique insights into tissue composition.

The ophthalmology segment is expected to have the highest CAGR during the forecast period

Because of the special powers of medical hyperspectral imaging to transform ocular diagnostics, the ophthalmology sector is predicted to grow profitably. Medical hyperspectral imaging in ophthalmology provides comprehensive insights into the retinal tissue, allowing for the accurate diagnosis of a variety of eye disorders, such as age-related macular degeneration and diabetic retinopathy. Moreover, the technology's capacity to extract spectral information from ocular tissues helps in the early diagnosis of abnormalities and offers useful information for customized therapies.

Region with largest share:

Owing to advancements in healthcare and growing technological usage, the Asia-Pacific region held the largest share. Modern medical imaging technologies are in high demand due to the region's expanding population and rising investments in healthcare infrastructure. The capacity of hyperspectral imaging to offer extensive spectral information for improved diagnosis of illnesses and surgical accuracy is in accordance with the region's increasing focus on cutting-edge medical technology. In addition, the prevalence of chronic illnesses like cancer and cardiovascular disorders has increased the demand for cutting-edge diagnostic tools, with hyperspectral imaging being offered as a revolutionary treatment.

Region with highest CAGR:

Asia Pacific region is expected to hold lucrative growth due to government initiatives in nations like China, India, and Japan that support healthcare infrastructure and research abilities. Technological innovation is continuously driven in the region by a robust research community and collaborations between academic institutions and industry participants. Furthermore, widespread acceptance has been fueled by rising expertise among medical professionals of the benefits of hyperspectral imaging in a wide range of medical applications, such as ophthalmology, dermatology, and oncology.

Key players in the market:

Some of the key players in Medical Hyperspectral Imaging market include Applied Spectral Imaging Inc, Bayspec Inc, Cubert GmbH, HyVista Corporation Pty Ltd, Inno-Spec GmbH, ITRES Research Limited, Norsk Elektro Optikk AS, Photonics Science Co, Resonon, Inc, Si-Ware Systems, Specim Spectral Imaging Ltd., Surface Optics Corporation and Tetracam Inc.

Key Developments:

In July 2022, Headwall Photonics announced the acquisition of Holographix LLC to expand its manufacturing capabilities to address future growth.

In June 2022, Resonon Inc. announced the launch of Pika IR-L and IR-L+ hyperspectral cameras (925 - 1700 nm).

Products Covered:

Accessories
Cameras
Portable Devices
Endoscopic Hyperspectral Imaging Devices
Integrated Systems
Other Products

Technologies Covered:

Whiskbroom Hyperspectral Imaging
Snapshot Hyperspectral Imaging
Pushbroom Hyperspectral Imaging
Other Technologies

Applications Covered:

Dermatology
Ophthalmology
Diagnostic Imaging
Surgical Imaging
Other Applications

End Users Covered:

Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Research and Academic Institutes
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Medical Hyperspectral Imaging Market, By Product

5.1 Introduction
5.2 Accessories
5.3 Cameras
5.4 Portable Devices
5.5 Endoscopic Hyperspectral Imaging Devices
5.6 Integrated Systems
5.7 Other Products

6 Global Medical Hyperspectral Imaging Market, By Technology

6.1 Introduction
6.2 Whiskbroom Hyperspectral Imaging
6.3 Snapshot Hyperspectral Imaging
6.4 Pushbroom Hyperspectral Imaging
6.5 Other Technologies

7 Global Medical Hyperspectral Imaging Market, By Application

7.1 Introduction
7.2 Dermatology
7.3 Ophthalmology
7.4 Diagnostic Imaging
7.5 Surgical Imaging
7.6 Other Applications

8 Global Medical Hyperspectral Imaging Market, By End User

8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Hospitals and Clinics
8.4 Research and Academic Institutes
8.5 Other End Users

9 Global Medical Hyperspectral Imaging Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Applied Spectral Imaging Inc
11.2 Bayspec Inc
11.3 Cubert GmbH
11.4 HyVista Corporation Pty Ltd
11.5 Inno-Spec GmbH
11.6 ITRES Research Limited
11.7 Norsk Elektro Optikk AS
11.8 Photonics Science Co
11.9 Resonon, Inc
11.10 Si-Ware Systems
11.11 Specim Spectral Imaging Ltd.
11.12 Surface Optics Corporation
11.13 Tetracam Inc

医療用ハイパースペクトルイメージングの世界市場予測（～2030年）：製品、技術、用途、エンドユーザー、地域別の分析

Medical Hyperspectral Imaging Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography

COVID-19の影響：

最もシェアの高い地域：

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の医療用ハイパースペクトルイメージング市場：製品別

第6章 世界の医療用ハイパースペクトルイメージング市場：技術別

第7章 世界の医療用ハイパースペクトルイメージング市場：用途別

第8章 世界の医療用ハイパースペクトルイメージング市場：エンドユーザー別

第9章 世界の医療用ハイパースペクトルイメージング市場：地域別

第10章 主な発展

第11章 企業プロファイル